pentol : A polyol with five hydroxy groups. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
ID Source | ID |
---|---|
PubMed CID | 9809915 |
SCHEMBL ID | 4132279 |
MeSH ID | M0085010 |
Synonym |
---|
25151-96-6 |
9-octadecenoic acid (z)-, 2,2-bis(hydroxymethyl)-1,3-propanediyl ester |
pentol |
9z47cc098o , |
einecs 246-665-2 |
9-octadecenoic acid (z)-, 2,2-bis(hydroxymethyl)-1,3-propanediyl |
2,2-bis(hydroxymethyl)-1,3-propanediyl dioleate |
unii-9z47cc098o |
9-octadecenoic acid, 2,2-bis(hydroxymethyl)-1,3-propanediylester |
ec 246-665-2 |
pentaerythrityl dioleate |
9-octadecenoic acid (9z)-, 1,1'-(2,2-bis(hydroxymethyl)-1,3-propanediyl) ester |
pentaerythritol dioleate |
(z)-9-octadecenoic acid, 2,2-bis(hydroxymethyl)-1,3-propanediyl ester |
dub dol pe |
oleic acid, 2,2-bis(hydroxymethyl)trimethylene ester |
pentaerythrityl dioleate [inci] |
aec pentaerythrityl dioleate |
radiasurf 7156 |
SCHEMBL4132279 |
W-110610 |
BJXXCOMGRRCAGN-CLFAGFIQSA-N |
Q27273402 |
pentaerythritoldioleate |
9-octadecenoic acid (9z)-, 1,1'-[2,2-bis(hydroxymethyl)-1,3-propanediyl] ester |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 3 (60.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.
| This Compound (87.12) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |